65 results on '"Alpha Foetoprotein"'
Search Results
2. Prothrombin induced by vitamin K absence or antagonist‐II and alpha foetoprotein to predict development of hepatocellular carcinoma in Caucasian patients with hepatitis C‐related cirrhosis treated with direct‐acting antiviral agents
- Author
-
Roberta D'Ambrosio, Sara Colonia Uceda Renteria, Pietro Lampertico, Alberto Perego, Corinna Orsini, Elisabetta Degasperi, Annalisa De Silvestri, Massimo Iavarone, Alessandro Rimondi, Angelo Sangiovanni, Ferruccio Ceriotti, Marta Borghi, Mariangela Bruccoleri, and Riccardo Perbellini
- Subjects
medicine.medical_specialty ,Cirrhosis ,Hepatology ,business.industry ,Hepatitis C virus ,Gastroenterology ,Antagonist ,Hepatitis C ,Vitamin k ,medicine.disease ,medicine.disease_cause ,digestive system diseases ,Internal medicine ,Hepatocellular carcinoma ,medicine ,Pharmacology (medical) ,business ,Alpha-fetoprotein ,Alpha Foetoprotein - Abstract
BACKGROUND Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) and alpha fetoprotein (AFP) are biomarkers for hepatocellular carcinoma (HCC). However, their performance in patients with cirrhosis related to hepatitis C virus (HCV) treated with direct-acting antiviral agents (DAA) is unknown. AIM To evaluate PIVKA-II and AFP as HCC predictors in DAA-treated patients with HCV-related cirrhosis METHODS: In this single centre study, patients with cirrhosis from chronic HCV infection and with a sustained virological response (SVR) to DAA were tested for PIVKA-II and AFP (Fujirebio, Japan) at the start of DAA treatment (baseline), end of treatment (EOT) and at HCC diagnosis. RESULTS We included 400 patients with mean age 65 (24-92); 56% were men. From baseline to EOT, PIVKA-II did not change (35 vs 35 mAU/mL, P = 0.43) while AFP significantly decreased (12 vs 6 ng/mL, P or ≤41 mAU/mL (P or ≤15 ng/mL (P = 0.02). By combining EOT-PIVKA-II and AFP, the 4-year probabilities of HCC were 3% in patients testing negative for both markers, 18% in patients positive for both, and 38% in patients positive for at least one (P
- Published
- 2021
3. T‐cell mediated responses against alpha‐foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival
- Author
-
Antonello Gibbin, G. Occhino, R. Minisini, Carlo Smirne, David J. Pinato, Mario Pirisi, E. Boccato, and Petros Fessas
- Subjects
business.industry ,Hepatitis C virus ,T cell ,Pharmaceutical Science ,medicine.disease_cause ,T cell response ,medicine.disease ,Phenotype ,Interleukin 10 ,medicine.anatomical_structure ,Complementary and alternative medicine ,Hepatocellular carcinoma ,medicine ,Cancer research ,Pharmacology (medical) ,business ,Alpha Foetoprotein - Published
- 2021
4. Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome.
- Author
-
Sakr, Mohammad, Abdelhakam, Sara M., Dabbous, Hany, Hamed, Amr, Hefny, Zeinab, Abdelmoaty, Waleed, Shaker, Mohamed, El-Gharib, Mohamed, and Eldorry, Ahmed
- Subjects
- *
BUDD-Chiari syndrome , *LIVER cancer , *HEPATIC veins , *CANCER risk factors , *COMPUTED tomography , *VENOGRAPHY , *MAGNETIC resonance imaging - Abstract
Background & Aim Budd-Chiari syndrome ( BCS) is caused by hepatic venous outflow obstruction. This work aimed at analyzing characteristics and factors associated with development of hepatocellular carcinoma ( HCC) in patients with primary BCS. Methods A total of 348 Egyptian BCS patients were included. They were presented to the Budd-Chiari Study Group of Ain Shams University Hospital. BCS was confirmed using abdominal Doppler US. Abdominal magnetic resonance imaging ( MRI), MR venography and/or multislice computed tomography ( CT) were performed to confirm all diagnoses and to assess vascular anatomy. Hepatic focal lesions detected during the study period (2005-2011) were evaluated using serum alpha foetoprotein ( AFP) level, imaging features and histopathological examination. Results Diagnosis of HCC was confirmed in 15/348 patients (4.3%). Imaging studies showed that 60% had multiple hepatic focal lesions ranging from 2 to 6.3 cm in size. The median level of serum AFP in BCS with HCC was 300 ng/mL vs 11 ng/mL in those without HCC ( P<.001). A cut-off level >24.5 ng/mL for serum AFP showed sensitivity 80%, specificity 97.9%, positive predictive value 93.18% and negative predictive value 99.1% for detection of HCC in BCS patients. Male gender, older age, cigarette smoking, serum AFP (>24.5 ng/mL) and shrunken liver by ultrasonography were independent factors associated with HCC development. Conclusion Male gender, older age and cigarette smoking are independent risk factors for development of HCC in BCS. Serum AFP is a good screening test in BCS. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
5. Paediatric Radiotherapy
- Author
-
Gattamaneni, H. Rao, Pearson, D., and Pointon, R. C. S., editor
- Published
- 1991
- Full Text
- View/download PDF
6. Changes in alpha‐foetoprotein and Gc‐globulin in relation to outcomes in non‐acetaminophen acute liver failure
- Author
-
Linda S. Hynan, Jody Rule, Sundeep Singh, and William M. Lee
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Vitamin D-binding protein ,Gastroenterology ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Humans ,Medicine ,In patient ,Aged ,Retrospective Studies ,Hepatology ,Receiver operating characteristic ,business.industry ,Vitamin D-Binding Protein ,digestive, oral, and skin physiology ,Liver failure ,Liver Failure, Acute ,Middle Aged ,digestive system diseases ,Acetylcysteine ,Acetaminophen ,Transplantation ,030220 oncology & carcinogenesis ,Female ,030211 gastroenterology & hepatology ,Absolute Change ,alpha-Fetoproteins ,business ,Alpha Foetoprotein ,Biomarkers ,medicine.drug - Abstract
Changes in Gc-globulin (Gc) and in alpha-foetoprotein (AFP) have been shown to be related to outcome in patients with acute liver failure (ALF). Gc is a serum protein that complexes with intravascular actin released during cellular necrosis. AFP, also made by hepatocytes, is associated with hepatocellular growth and regeneration. Previously, low absolute levels or decreases over time in either AFP or Gc portended to be a poor outcome.In a retrospective analysis of the double-blind trial of intravenous N-acetylcysteine (NAC) for ALF not because of acetaminophen, sera on days 1 and 3 or days 2 and 4 following admission were available to measure AFP in 70 patients and Gc in 66 patients. Mann-Whitney U tests were performed on the admission values, the absolute change and the fractional change of AFP and Gc to compare TFS (transplant-free survival) and non-TFS (death or transplantation). Logistic regression and receiver operating characteristic (ROC) analyses were performed to evaluate the markers in comparison and in addition to King's College Criteria (KCC).Transplant-free survival patients were characterized by increases in AFP, whereas non-TFS had significantly different (negative) absolute and fractional changes (P .01). The addition of declining AFP levels to KCC improved the area under the curve in predicting non-TFS (AUC70%). Gc globulin values did not differ between TFS and non-TFS in the 2-day intervals studied (P .2).In this comparison of two prognostic markers in patients with non-acetaminophen-induced ALF, rising AFP but not rising Gc levels was associated with TFS.ClinicalTrials.gov number NCT00004467.
- Published
- 2019
7. Author response to Letter to the Editor: 'Chronological change in alpha-foetoprotein levels in hepatocellular carcinoma after eradication of hepatitis C virus'
- Author
-
Vincent L. Chen and Neehar D. Parikh
- Subjects
Letter to the editor ,Carcinoma, Hepatocellular ,Insurance, Health ,Hepatology ,business.industry ,Hepatitis C virus ,Liver Neoplasms ,Hepacivirus ,medicine.disease_cause ,medicine.disease ,Virology ,Hepatitis C ,Hepatocellular carcinoma ,Medicine ,Humans ,alpha-Fetoproteins ,business ,Alpha Foetoprotein - Published
- 2020
8. A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir
- Author
-
Cheng Yuan Peng, Hsueh Chou Lai, Chao-Hung Hung, Chuan Mo Lee, Tsung Hui Hu, Hung Hsien Chiang, Wen-Pang Su, Chia Hsin Lin, Sheng Nan Lu, Jing Houng Wang, and Chien-Hung Chen
- Subjects
Adult ,Liver Cirrhosis ,Male ,China ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Guanine ,Multivariate analysis ,Cirrhosis ,Diabetic mellitus ,Taiwan ,Independent predictor ,Antiviral Agents ,Gastroenterology ,03 medical and health sciences ,Hepatitis B, Chronic ,0302 clinical medicine ,Chronic hepatitis ,Internal medicine ,medicine ,Humans ,Aspartate Aminotransferases ,Aged ,Proportional Hazards Models ,Retrospective Studies ,Hepatology ,Platelet Count ,business.industry ,Incidence ,Liver Neoplasms ,Alanine Transaminase ,Entecavir ,Middle Aged ,medicine.disease ,digestive system diseases ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Multivariate Analysis ,Female ,030211 gastroenterology & hepatology ,alpha-Fetoproteins ,business ,Alpha Foetoprotein ,Biomarkers ,medicine.drug - Abstract
Background & aims This study investigates the long-term incidences and predictors of developing hepatocellular carcinoma (HCC), cirrhotic events and mortality in cirrhotic patients receiving entecavir (ETV) therapy. Methods We enrolled 481 nucleos(t)ide analogue-naive chronic hepatitis B (CHB) patients who had compensated cirrhosis upon entry and had received ETV monotherapy for >12 months. Results The 8-year cumulative incidences of developing HCC, cirrhotic events and liver-related mortality were 26.5%, 8.62% and 10.03% respectively. Multivariate analysis revealed that diabetic mellitus (DM), higher fibrosis-4 (FIB-4) and alpha-foetoprotein (AFP) levels at 12 months of treatment, and FIB-4 increase from baseline to 12 months were independent factors of HCC. FIB-4 and AFP levels at 12 months of treatment were also independent factors of cirrhotic events and mortality. FIB-4 cut-off values of 3, 3 and 5 as well as AFP cut-offs of 5, 5, and 9 ng/mL at 12 months of treatment were optimal for predicting HCC, cirrhotic events and mortality during therapy respectively. The FIB-4 and AFP levels at 12 months of treatment were assessed for the combined risk of developing clinical outcomes. The 8-year incidences of HCC, cirrhotic events and liver-related mortality in the subgroups with low FIB-4 and AFP levels were only 5.95%, 1.03% and 2.43% respectively. DM was an independent predictor of HCC and mortality. Conclusion The combination of FIB-4 and AFP levels at 12 months of treatment is a useful marker for predicting the development of HCC, cirrhotic events and mortality in compensated cirrhotic patients with CHB who are receiving ETV therapy.
- Published
- 2018
9. Caractéristiques immuno-analytiques de l’alpha fœtoprotéine.
- Author
-
Desbene, C. and Gaillard, O.
- Subjects
ALPHA fetoproteins ,IMMUNE system ,MOLECULAR structure ,IMMUNOASSAY ,PROTEIN analysis ,DATA analysis ,PROTEIN structure - Abstract
Copyright of IBS, Immuno-analyse & Biologie Specialisee is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2013
- Full Text
- View/download PDF
10. Serum interleukin-18: Does it have a role in the diagnosis of hepatitis C virus related hepatocellular carcinoma?
- Author
-
Mohran, Zakaria Y., Ali-Eldin, Fatma A., and Abdel Aal, Hala A.
- Subjects
INTERLEUKINS ,SERUM ,HEPATITIS C virus ,HEPATITIS C treatment ,LIVER cancer ,PREVENTIVE medicine - Abstract
Abstract: Background and study aims: Early diagnosis of hepatocellular carcinoma (HCC) is the only hope for cure. Although the role of alpha foetoprotein (AFP) in the diagnosis of advanced HCC is well recognised, at least one-third of cases will be missed unless another diagnostic tool is used. Increased levels of circulating interleukin-18 (IL-18) have been observed in patients with several cancer types and were described in patients with chronic hepatitis. The aim of this study is to assess the role of serum IL-18 level in the diagnosis of hepatitis C virus (HCV)-related HCC. Patients and methods: A total of 75 subjects categorised into four groups, including 25 patients with HCV-related HCC and AFP above 200ng/ml, 25 patients with HCV-related HCC and AFP below 200ng/ml, 15 patients with HCV-related chronic liver disease and 10 healthy controls, were enrolled. HCC was diagnosed according to guidelines of the American Association for the Study of Liver Diseases. AFP and IL-18 were assessed in all subjects. Results: AFP and IL-18 levels are significantly higher in patients with HCC than in disease control and healthy control subjects. IL-18 level is not correlating with the size or the number of hepatic focal lesions neither with the presence of lymphovascular invasion or abdominal lymphadenopathy. The best cut-off value of IL-18 for the diagnosis of HCC is 500pg/ml with 84% sensitivity and 86.7% specificity and the area under receiver operating characteristic curve is 0.675. Conclusion: Serum IL-18 level is a suitable marker for the diagnosis of HCV-related HCC complementary to AFP, especially in cases with AFP level less than the diagnostic value. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
11. Screening for hepatocellular carcinoma.
- Author
-
Sherman, Morris
- Subjects
LIVER cancer ,MEDICAL screening ,CANCER diagnosis ,DIAGNOSTIC imaging ,LIVER transplantation ,MORTALITY ,TOMOGRAPHY ,MAGNETIC resonance imaging - Abstract
There is currently no evidence that screening patients at risk for hepatocellular carcinoma reduces mortality from the disease. Nonetheless, screening is widely practiced. Screening is a process that includes selecting patients, applying screening tests, deciding on recall policies, and subsequently proving or disproving the presence of cancer. The literature on screening for hepatocellular carcinoma is confusing at best, and does not adequately consider the many biases that result from uncontrolled and retrospective studies. Nonetheless, screening can be justified because it is likely that mortality is decreased by adequate treatment of small cancers, particularly in the era of liver transplantation. False-positive screening test results are common. Once an abnormal screening result is obtained there is little guidance from the literature as to how patients should be investigated further, nor about how to determine whether the screening test result was a false-positive. This should at minimum include short interval follow-up with CT scans and MRI''s. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
12. Risk stratification for locally advanced hepatocellular carcinoma using pretreatment alpha-foetoprotein and18F-fluoro-2-deoxyglucose positron emission tomography
- Author
-
Sang Hyun Hwang, Kwang Hyub Han, Mijin Yun, Woo Joong Rhee, Hwa Kyung Byun, and Jinsil Seong
- Subjects
Hepatology ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Deoxyglucose ,Locally advanced ,medicine.disease ,Radiation therapy ,03 medical and health sciences ,0302 clinical medicine ,Positron emission tomography ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Risk stratification ,Medicine ,030211 gastroenterology & hepatology ,Clinical significance ,business ,Nuclear medicine ,Alpha Foetoprotein - Abstract
Background & Aims We investigated the significance of 18F-fluoro-2-deoxyglucose positron emission tomography (18F-FDG PET) parameters and alpha-foetoprotein (AFP) levels in patients with locally advanced hepatocellular carcinoma (LA-HCC). Methods We retrospectively analysed data of 228 patients with LA-HCC who underwent pretreatment 18F-FDG PET between January 2003 and December 2013. All patients were treated using liver-directed therapy involving radiotherapy. The maximum standardized uptake values (SUVs) and tumour-to-extratumoural liver SUV ratios were calculated, and pretreatment AFP values were obtained. Results Patients were divided into high and low maximum SUV (SUVmax) groups according to a SUV cut-off of 4.825 determined via receiver-operating characteristic analysis. High AFP level (>550 ng/mL) and high SUVmax were significant predictors of overall and progression-free survival. Better treatment responses and longer median progression-free and overall survival were observed in the low SUVmax group, compared to the high SUVmax group. Similar results were obtained for SUV ratio-based (cut-off value: 2.355) and AFP-based analyses (cut-off value: 550 ng/mL). Three risk groups were identified using the double biomarkers of SUVmax and AFP value as strong prognosticators predictive of survival outcomes. This risk stratification was identified as a prognosticator of survival outcomes, even after subgroup analyses. Furthermore, in high risk group, significantly high extrahepatic failure was shown while in low risk group, significantly low intrahepatic failure. Conclusions Clinical significance of double biomarkers, SUV and AFP, could be translated into risk stratification for LA-HCC. It could be a valuable tool for survival outcome prediction.
- Published
- 2016
13. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma. A diagnostic test accuracy Cochrane review
- Author
-
Damir Miletić, Giovanni Casazza, Davor Štimac, Mirella Fraquelli, Agostino Colli, Tin Nadarević, and Vanja Giljaca
- Subjects
medicine.medical_specialty ,Hepatology ,Abdominal ultrasound ,business.industry ,Hepatocellular carcinoma ,Gastroenterology ,medicine ,Diagnostic test ,Radiology ,medicine.disease ,business ,Alpha Foetoprotein - Published
- 2021
14. Discovery of Hereditary Tyrosinemia in Saguenay- Lac St-Jean
- Author
-
Jean Larochelle
- Subjects
0301 basic medicine ,Hereditary tyrosinemia ,Genetics ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,business.industry ,Medicine ,business ,Alpha Foetoprotein ,030217 neurology & neurosurgery - Abstract
Given the interest of many people and families directly or indirectly affected by hereditary tyrosinemia (HT1), I have tried to give my view on the history of the disease from 1965 to 2015 (Fig. 1.1).
- Published
- 2017
15. Caractéristiques immuno-analytiques de l’alpha fœtoprotéine
- Author
-
O. Gaillard and C. Desbene
- Subjects
Biochemistry (medical) ,Clinical Biochemistry ,Immunology ,Sampling (statistics) ,Computational biology ,Biology ,Alpha Foetoprotein - Abstract
Summary Besides structural and physiological data of alpha foetoprotein, this paper points out the optimal conditions for sampling, assays and interpretation of results.
- Published
- 2013
16. Paediatric Radiotherapy
- Author
-
Pearson, D., Easson, Eric C., editor, and Pointon, R. C. S., editor
- Published
- 1985
- Full Text
- View/download PDF
17. Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma
- Author
-
Bruno Chauffert, Aline Houessinon, Jean-Claude Barbare, Alexandra Petit, Chloé Sauzay, Antoine Galmiche, and Anne-Marie Bourgeois
- Subjects
0301 basic medicine ,Sorafenib ,Oncology ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,medicine.medical_treatment ,Clinical Biochemistry ,Context (language use) ,Biology ,Liver transplantation ,Bioinformatics ,Biochemistry ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Biomarkers, Tumor ,Humans ,neoplasms ,digestive, oral, and skin physiology ,Biochemistry (medical) ,Liver Neoplasms ,General Medicine ,medicine.disease ,digestive system diseases ,Clinical Practice ,030104 developmental biology ,Proteostasis ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,embryonic structures ,alpha-Fetoproteins ,Alpha Foetoprotein ,medicine.drug - Abstract
Alpha-foetoprotein (AFP), one of the first protein tumour markers discovered, is widely used today in clinical practice. Its application for the screening and diagnosis of hepatocellular carcinoma (HCC), the most frequent form of primary liver tumour, is a matter of extensive debate. In addition to the studies focused on the role of the AFP in the diagnosis of HCC, in recent years AFP has been used to guide the therapeutic choice in HCC and monitor the treatment. Here, we summarize the latest studies that show the interest of AFP quantification in determining the suitability of liver transplantation or to follow-up on patients receiving the targeted treatment sorafenib. We also highlight the recent studies showing the active role of AFP in tumour progression, and the new modes of regulation of this tumour marker. Among these is the regulation of AFP through tumour proteostasis and the Unfolded Protein Response (UPR). We discuss the implications of this new knowledge in the therapeutic context, in terms of interpreting serum levels of AFP, and the new perspectives offered by AFP for the study of tumour proteostasis.
- Published
- 2016
18. Alpha-foetoprotein: further evidence to add a biological marker to refine Milan criteria
- Author
-
Christian Toso, Roberto Hernandez-Alejandro, Pietro Majno, Axel Andres, and Norman M. Kneteman
- Subjects
Carcinoma, Hepatocellular ,Hepatology ,business.industry ,Liver Neoplasms ,Computational biology ,030230 surgery ,Milan criteria ,Liver Transplantation ,03 medical and health sciences ,0302 clinical medicine ,Medicine ,Humans ,030211 gastroenterology & hepatology ,alpha-Fetoproteins ,business ,Alpha Foetoprotein ,Biomarkers - Published
- 2016
- Full Text
- View/download PDF
19. Liver transplantation for hepatocellular cancer: UCL experience in 137 adult cirrhotic patients. Alpha-foetoprotein level and locoregional treatment as refined selection criteria
- Author
-
Pierre Goffette, Erik Doffagne, Jan Lerut, Christine Sempoux, Francine Roggen, Olga Ciccarelli, Raymond Reding, Patrice Finet, Quirino Lai, and Chantal De Reyck
- Subjects
Transplantation ,medicine.medical_specialty ,Hepatocellular cancer ,Multivariate analysis ,business.industry ,medicine.medical_treatment ,Retrospective cohort study ,Liver transplantation ,Milan criteria ,Single Center ,Gastroenterology ,Internal medicine ,medicine ,Risk factor ,business ,Alpha Foetoprotein - Abstract
Liver transplantation (LT) is a validated treatment for selected cirrhotics with hepatocellular cancer (HCC). A retrospective single center study including 137 recipients having proven HCC was done to refine inclusion criteria for LT as well as to look at impact of locoregional treatment (LRT) on outcome. At pre-LT imaging, 42 (30.6%) patients were Milan criteria (MC)-OUT; 28 (20.4%) were University of California San Francisco criteria (UCSFC)-OUT. Pre-LT LRT was performed in 109 (79.6%) patients. Multivariate analysis identified four factors to be independently predictive of recurrence: tumour number >3, AFP level ≥400 ng/ml, microvascular invasion and rejection needing anti-lymphocytic antibodies. When considering pre-transplant variables only, AFP level ≥400 ng/ml (HR = 5.13; P
- Published
- 2012
20. Management of hepatocellular carcinoma in the waiting list before liver transplantation
- Author
-
Emiliano Giostra, Antoine Hadengue, Philippe Morel, Pietro Majno, and Gilles Mentha
- Subjects
medicine.medical_specialty ,Carcinoma, Hepatocellular ,Waiting Lists ,Hepatology ,business.industry ,medicine.medical_treatment ,General surgery ,Liver Neoplasms ,Liver transplantation ,medicine.disease ,Liver Transplantation ,Surgery ,Model for End-Stage Liver Disease ,Waiting list ,Hepatocellular carcinoma ,medicine ,Humans ,Percutaneous ethanol injection ,business ,Living donor liver transplantation ,Alpha Foetoprotein - Published
- 2005
21. Mesenchymal Hamartomas of the Liver May Be Associated with Increased Serum Alpha Foetoprotein Concentrations and Mimic Hepatoblastomas
- Author
-
Bonnevalle M, Bossard C, Diab N, Boccon-Gibod L, Boman F, and Fabre M
- Subjects
Hepatoblastoma ,Gynecology ,medicine.medical_specialty ,business.industry ,Hamartoma ,Liver Diseases ,Liver Neoplasms ,Mesenchymal stem cell ,Infant ,medicine.disease ,Mesenchymal hamartoma ,Diagnosis, Differential ,Endocrinology ,Liver ,Internal medicine ,Pediatrics, Perinatology and Child Health ,Hepatocytes ,medicine ,Humans ,Female ,Surgery ,alpha-Fetoproteins ,business ,Alpha Foetoprotein - Abstract
Un hamartome mesenchymateux (HM) du foie chez une petite fille âgee de sept mois etait associe avec une discrete augmentation du taux serique d'alpha foetoproteine (AFP) (320 pgJL, taux normal < 25 apresl'âge de six mois). L'examen anatomopathologique mettait en evidence un contingent hepatocellulaire abondant a la peripherie de la tumeur. Les hepatocytes tumoraux etaient legerement atypiques et exprimaient l'AFP en immunohistochimie. Chez deux autres petites filles âgees respectivement de 14 mois et deux mois, presentant un HM et un taux augmente d'AFP (320 μg/L et 7500 μg/L, respectivement), le diagnostic preoperatoire d'hepatoblastome a ete pose a tort. L'HM du foie s'accompagnant d'un taux serique augmente d'AFP peut donc simuler un hepatoblastome radiologiquement dans les cas ou les kystes manquent, et un hepatoblastome foetal a l'examen anatomo-pathologique si un prelevement biopsique interesse seulement le contingent hepatocellulaire peripherique de l'HM.
- Published
- 2004
22. Hepatocellular carcinoma — History, current status and perspectives
- Author
-
K. Okuda
- Subjects
Hepatitis B virus ,Carcinoma, Hepatocellular ,Hepatology ,business.industry ,Incidence ,Hepatitis C virus ,medicine.medical_treatment ,Liver Neoplasms ,Gastroenterology ,History, 20th Century ,medicine.disease_cause ,medicine.disease ,Virology ,Liver Transplantation ,Japan ,Hepatocellular carcinoma ,medicine ,Humans ,Percutaneous ethanol injection ,business ,Alpha Foetoprotein ,Des γ carboxy prothrombin - Published
- 2002
23. Alpha-foetoprotein in the diagnosis of prelabour rupture of membranes
- Author
-
Rajeshwari G Bhat and Chhavi Rana Singh
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,lcsh:R ,Clinical Biochemistry ,lcsh:Medicine ,Gestational age ,Perinatal outcome ,General Medicine ,Prom ,female genital diseases and pregnancy complications ,Obstetrics and Gynaecology Section ,alpha-foetoprotein ,medicine.anatomical_structure ,Vagina ,combined clinical diagnosis ,Gestation ,Medicine ,Rupture of membranes ,prelabour rupture of membranes ,business ,Prospective cohort study ,Alpha Foetoprotein - Abstract
Content: Prelabour rupture of membranes (PROM) complicates overall 10% of gestations which include 7% at term and 3 % preterm gestations. Making an early and accurate diagnosis of PROM is important, to allow gestational age specific obstetric interventions and to optimize perinatal outcome. Objective: To study the efficacy of alpha-foeto protein in cervicovaginal secretions, to diagnose prelabour rupture of membranes. Setting: A tertiary care centre. Materials and Methods: We performed a prospective study on 130 patients who were at ≥ 24 weeks of gestation, who had complaint of leaking per vagina, between September 2011 and August 2013. Alpha-foetoprotein test was perfomed on cervicovaginal secretions which were collected during per-speculum examinations. A diagnosis of prelabour rupture of membranes was made, based on combined clinical diagnosis which was made during hospital stay of the patients prospectively. The efficacy of Alpha-foetoprotein was studied. Stastical Analysis: Chi-square test, Kappa analysis. Results: The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of Alpha-foetoprotein were 88.9%, 98.5%, 98.3%, 90.1% and 93.8% respectively. Degree of agreement of Alpha-foetoprotein with combined clinical diagnosis was 0.875. Conclusion: Assessment of alpha-foetoprotein levels in cervi-covaginal secretions can be used as a reliable test to diagnose prelabour rupture of membranes when faced with a diagnostic dilemma.
- Published
- 2013
24. Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma
- Author
-
Do Young Kim, Sang Hoon Ahn, Hana Park, Jun Young Park, Seung Up Kim, Jinsil Seong, Chae Yoon Chon, and Kwang Hyub Han
- Subjects
Adult ,Male ,Treatment completion ,medicine.medical_specialty ,Pathology ,Carcinoma, Hepatocellular ,Treatment outcome ,Locally advanced ,Gastroenterology ,Internal medicine ,Republic of Korea ,Overall survival ,Medicine ,Humans ,In patient ,Protein Precursors ,neoplasms ,Aged ,Ultrasonography ,Analysis of Variance ,Hepatology ,business.industry ,Liver Neoplasms ,Middle Aged ,medicine.disease ,Prognosis ,Response to treatment ,Magnetic Resonance Imaging ,Survival Analysis ,digestive system diseases ,Hepatocellular carcinoma ,Area Under Curve ,embryonic structures ,Female ,Prothrombin ,alpha-Fetoproteins ,business ,Tomography, X-Ray Computed ,Alpha Foetoprotein ,Biomarkers - Abstract
Background & Aims In this study, we investigated the clinical usefulness of AFP and PIVKA-II in subdividing prognostic groups in patients with locally advanced HCC treated locally. Methods Patients who had undergone local treatment for locally advanced HCC between 2001 and 2006 were enrolled. Response to treatment was defined as a reduction in AFP or PIVKA-II by more than 50% from baseline levels at 1 month after the treatment completion. Patients were divided according to their AFP and PIVKA-II response: A↓P↓ [AFP response (+) and PIVKA-II response (+)]; A↓P↑ [AFP response (+) and PIVKA-II response (−)]; A↑P↓ [AFP response (−) and PIVKA-II response (+)]; A↑P↑ [AFP response (−) and PIVKA-II response (−)]. Clinical characteristics and prognosis were compared between groups. Results Patients were subdivided into four groups by the change in the level of the biomarkers AFP and PIVKA-II, and the survival outcomes of each group were distinct. Among patients with an AFP response, further subdivision by PIVKA-II response revealed that those in the A↓P↓ group had a longer median progression-free survival (PFS) and overall survival (OS) compared with those in the A↓P↑ group (PFS: 16.2 vs. 5.1 months, P = 0.009; OS: 26.3 vs. 7.3 months, P = 0.017). Combination of AFP and PIVKA-II response showed a predictive power for PFS and OS comparable to radiological criteria and better than AFP response alone. Conclusions In patients with locally advanced HCC, the use of a combination of two biomarkers, AFP and PIVKA-II, appears useful in predicting treatment outcomes through the subdivision of prognostic groups.
- Published
- 2013
25. Ablation and resection for hepatocellular carcinoma within Milan criteria and high alpha-foetoprotein levels
- Author
-
Rita Golfieri, Alessandro Cucchetti, Franco Trevisani, Cucchetti, Alessandro, Golfieri, Rita, and Trevisani, Franco
- Subjects
medicine.medical_specialty ,Carcinoma, Hepatocellular ,medicine.medical_treatment ,hepatic resection ,Catheter ablation ,Liver transplantation ,Milan criteria ,ablation ,Resection ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Hepatectomy ,Humans ,Hepatology ,business.industry ,General surgery ,Liver Neoplasms ,hepatocellular carcinoma ,medicine.disease ,Ablation ,Liver Transplantation ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Catheter Ablation ,030211 gastroenterology & hepatology ,Radiology ,business ,Alpha Foetoprotein - Abstract
NA
- Published
- 2016
26. Alpha-foetoprotein producing endometrial serous carcinoma
- Author
-
Rashpal Flora, Suraiya Dubash, Mona El-Bahawy, and Alexandra Taylor
- Subjects
Gynecology ,Cancer Research ,Fetus ,medicine.medical_specialty ,Poor prognosis ,Serous carcinoma ,business.industry ,medicine.disease ,Gastroenterology ,digestive system diseases ,Serous fluid ,medicine.anatomical_structure ,Oncology ,Internal medicine ,medicine ,Carcinoma ,Radiology, Nuclear Medicine and imaging ,Germ cell tumors ,Yolk sac ,business ,Alpha Foetoprotein - Abstract
Elevated serum levels of alpha-fetoprotein, a fetal serum protein, occurs on development of hepatoma or germ cell tumors, mainly yolk sac tumor. Very few cases of endometrial carcinoma associated with elevated serum alpha-fetoprotein have been reported. It is important to be aware of such entities to ensure correct diagnosis and hence patient management. We report a case of a 71 years old lady presenting with postmenopausal bleeding and elevated serum alpha-fetoprotein. Investigations confirmed the patient had an alpha-fetoprotein producing endometrial serous carcinoma. This is the third case of alpha-foetoprotein producing serous carcinoma. We discuss the clinicopathological features of the case and review the literature for previously reported alpha-fetoprotein producing endometrial carcinomas. These cases show aggressive behavior and very poor prognosis.
- Published
- 2011
27. Alpha-foetoprotein levels in the neonatal period
- Author
-
Tamer Gunes, Mehmet Adnan Ozturk, Selim Kurtoglu, Mustafa Akcakus, and Esad Koklu
- Subjects
medicine.medical_specialty ,Alpha fetoprotein levels ,business.industry ,Obstetrics ,Period (gene) ,Reference values ,Pediatrics, Perinatology and Child Health ,Medicine ,business ,Alpha Foetoprotein - Published
- 2008
28. HCV core protein and the expression of the alpha-foetoprotein gene
- Author
-
C.-G. Wu, S.H. Yap, Chris Verslype, and J. van Pelt
- Subjects
Hcv core ,Hepatology ,Biology ,Gene ,Alpha Foetoprotein ,Molecular biology - Published
- 1998
29. Use of biological sample banks in epidemiological studies
- Author
-
Nicholas J. Wald
- Subjects
Male ,medicine.medical_specialty ,Lung Neoplasms ,Sample (material) ,Urine ,Medical disorder ,General Biochemistry, Genetics and Molecular Biology ,Direct measure ,Pregnancy ,Environmental health ,Epidemiology ,Birth Weight ,Humans ,Mass Screening ,Medicine ,Neural Tube Defects ,Vitamin A ,business.industry ,Smoking ,Obstetrics and Gynecology ,Immunology ,Blood Banks ,Female ,Tobacco Smoke Pollution ,alpha-Fetoproteins ,Down Syndrome ,Epidemiologic Methods ,business ,Alpha Foetoprotein - Abstract
Serum and urine banks have proved to be useful in the conduct of epidemiological studies. Samples collected as part of a large prospective study can be stored and retrieved later for laboratory analyses, selecting samples from groups of special interest and also from matched controls. The applications of the method are considered under three headings: firstly as a marker of a medical disorder, secondly as a measure of the extent of exposure to a harmful agent and thirdly as a direct measure of a suspected harmful or protective agent. Examples of each are given. Banks of biological samples other than serum or urine, such as hair and nail, are now being formed. The scientific opportunities of these collections are great and it will be of interest to see how they will be used.
- Published
- 1985
30. Suppression of human alpha-foetoprotein-producing hepatocellular carcinoma growth in nude mice by an anti alpha-foetoprotein antibody-daunorubicin conjugate with a poly-L-glutamic acid derivative as intermediate drug carrier
- Author
-
Y Tsukada, N Hibi, and Kiyoshi Ohkawa
- Subjects
Cytotoxicity, Immunologic ,Cancer Research ,Daunorubicin ,Antibodies, Neoplasm ,Mice, Nude ,Mitosis ,Antibodies ,chemistry.chemical_compound ,Mice ,Liver Neoplasms, Experimental ,medicine ,Animals ,Mice, Inbred BALB C ,biology ,business.industry ,Body Weight ,Glutamic acid ,medicine.disease ,Molecular biology ,Oncology ,chemistry ,Polyglutamic Acid ,Hepatocellular carcinoma ,Immunology ,biology.protein ,alpha-Fetoproteins ,Antibody ,Pharmaceutical Vehicles ,business ,Drug carrier ,Alpha Foetoprotein ,Derivative (chemistry) ,Conjugate ,medicine.drug ,Research Article - Abstract
Suppression of human α-foetoprotein-producing hepatocellular carcinoma growth in nude mice by an anti α-foetoprotein antibody-daunorubicin conjugate with a poly-L-glutamic acid derivative as intermediate drug carrier
- Published
- 1985
31. Serum and tissue markers of testicular tumours
- Author
-
Paul H. Lange
- Subjects
endocrine system ,medicine.medical_specialty ,Pathology ,urogenital system ,business.industry ,Chorionic gonadotrophin ,Urology ,Endocrinology, Diabetes and Metabolism ,Seminoma ,medicine.disease ,Rate analysis ,Endocrinology ,Placental alkaline phosphatase ,Reproductive Medicine ,Tissue markers ,Internal medicine ,Medicine ,Testicular tumours ,business ,Alpha Foetoprotein ,reproductive and urinary physiology ,Testicular cancer - Abstract
This article reviews the value of the tumour markers alpha-foetoprotein (AFP) and human chorionic gonadotrophin (hCG) in the management of patients with testicular germ-cell tumours, especially non-seminomatous tumours. Recent developments in their use, such as metabolic decay rate analysis, are discussed. Possible new markers for testicular cancer, particularly SP-1 and placental alkaline phosphatase, are reviewed.
- Published
- 1981
32. Isolation and characterization of alpha-foetoprotein from foetal pigs
- Author
-
W Karlsson Borje, Roland Carlsson, and Benot I. Ingvarsson
- Subjects
Sedimentation coefficient ,Electrophoresis ,Isoelectric point ,Chromatography ,Globulin ,embryonic structures ,biology.protein ,Biology ,Biochemistry ,Molecular biology ,Alpha Foetoprotein ,Polyacrylamide gel electrophoresis - Abstract
1. 1. Porcine α-foetoprotein, APP, was isolated from serum of pig foetuses using preparative electrophoresis and irnmunosorbent techniques. 2. 2. The purity of the isolated AFP was controlled by polyacrylamide gel electrophoresis, electro-immunoassay and by injection of isolated AFP into rabbits. 3. 3. During the preparation of AFP from foetal pig serum an unexpected α 1 -globulin appeared as a contaminating protein. 4. 4. The molecular weight, isoelectric point and sedimentation coefficient were found to be 70,000, 4–61 and 4–56 respectively. No microheterogeneity as regards the physicochemical parameters investigated could be seen. The results were compared with those reported for some other mammals.
- Published
- 1976
33. Ultrasound scanning in pregnancy: Consumer reactions
- Author
-
DipClinPsychol Myra Hunter BSc and Mona M. Tsoi BSocSc
- Subjects
Gynecology ,medicine.medical_specialty ,Pregnancy ,business.industry ,Obstetrics ,Ultrasound ,Obstetrics and Gynecology ,medicine.disease ,Opinion survey ,Reproductive Medicine ,Pediatrics, Perinatology and Child Health ,medicine ,business ,Obstetric Procedure ,Alpha Foetoprotein ,General Psychology - Abstract
This study assessed the reactions of pregnant women who received ultrasound examination during their pregnancy. The subjects included 30 women who were diagnosed to have raised serum alpha foetoprotein (AFP) in a previous bloodtest and ultrasound scanning was therefore performed to further diagnose foetal abnormalities. Another 30 pregnant women receiving routine scanning for dates also served as subjects. The women were interviewed before and immediately after scanning and a questionnaire was sent to them four weeks after the examination. Results indicated that following scanning the subjects rated the procedure to be less distressing or less physically uncomfortable than they had initially expected. Most of them described the experience as ‘wonderful’ and ‘fine’. The follow-up opinion survey further confirmed that the women were satisfied with the procedures. Their responses highlighted the importance of giving feedback and allowing time to talk to the doctors when such an obstetric procedure w...
- Published
- 1987
34. Immunoelectrophoretic Quantitation of Maternal Serum Human Placental Lactogen Hormone and Alpha-Foetoprotein in the Same Electrophoretic Run
- Author
-
B. Nørgaard-Pedersen and P. GæDE
- Subjects
medicine.medical_specialty ,integumentary system ,medicine.diagnostic_test ,Coomassie Brilliant Blue ,digestive, oral, and skin physiology ,Immunology ,General Medicine ,Immunoelectrophoresis ,Biology ,digestive system diseases ,Quantitative determination ,chemistry.chemical_compound ,Endocrinology ,Human placental lactogen ,chemistry ,Internal medicine ,embryonic structures ,medicine ,neoplasms ,Alpha Foetoprotein ,Hormone - Abstract
A technique for quantitative determination of human placental lactogen (HPL) hormone and alpha-foetoprotein (AFP) in serum or plasma in the same rocket immunoelectrophoresis is described. The HPL rockets are stained with Coomassie brilliant blue and the AFP rockets are visualized by auto-radiography or by a spark chamber technique. Sixty-seven HPL-AFP estimates were made on different sera from 21 women with twin pregnancies. Both the HPL and AFP concentrations were higher in serum from twin pregnancies than in serum from single pregnancies. The diagnostic use of the combined HPL-AFP assay, especially in the early diagnosis of twin pregnancies and of neural tube malformations, is discussed.
- Published
- 1975
35. Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma
- Author
-
W M Melia, Richard Alun Williams, Philip J. Johnson, Michael K Palmer, and B. Portmann
- Subjects
Adult ,Liver Cirrhosis ,Male ,Cancer Research ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Cirrhosis ,Multivariate analysis ,Adolescent ,Gastroenterology ,Internal medicine ,medicine ,Humans ,In patient ,Aged ,business.industry ,Liver Neoplasms ,Single factor ,Age Factors ,Middle Aged ,Prognosis ,medicine.disease ,Natural history ,Oncology ,Hepatocellular carcinoma ,Female ,alpha-Fetoproteins ,Liver cancer ,business ,Alpha Foetoprotein ,Research Article - Abstract
An analysis of survival time of 57 West European patients with hepatocellular carcinoma was carried out to define which of several possible factors (age, sex, cirrhosis and raised serum alpha-foetoprotein (AFP)) influenced survival. Although survival was significantly longer in younger patients (P less than 0.02) and in patients with normal serum AFP (P less than 0.01), multivariate analysis showed that significant variation in survival time is better explained by the single factor, the presence of cirrhosis, than by AFP level. This does not seem to apply for patients with this tumour in Africa and the Far East, and there may be a fundamental difference in the natural history of the tumour between high- and low-incidence areas.
- Published
- 1981
36. Lack of serological homology between chicken alpha‐foetoprotein, chicken foetal red blood cell antigen and Marek's disease tumour‐associated surface antigen1
- Author
-
U. Neumann
- Subjects
Marek's disease ,animal structures ,General Immunology and Microbiology ,biology ,medicine.diagnostic_test ,biology.organism_classification ,Immunofluorescence ,Virology ,Molecular biology ,Homology (biology) ,Serology ,Red blood cell ,medicine.anatomical_structure ,Food Animals ,Antigen ,embryonic structures ,medicine ,Animal Science and Zoology ,Alpha Foetoprotein - Abstract
Summary In the course of immunofluorescence absorption studies it was found that, besides Marek's disease tumour‐associated surface antigen (MATSA), two foetal antigens could be distinguished on MSB‐1 line cells, one of which was chicken foetal red blood cell antigen (chFRBC) and another chicken alpha‐foetoprotein (chAFP). The experiments suggest a lack of homology between the three antigens.
- Published
- 1980
37. Excretion of alpha-foetoprotein in the urine of rats during exposure to 3'-methyl-4-dimethylaminoazobenzene
- Author
-
E Okon, E. Rosenmann, G. Zajicek, and J. H. Boss
- Subjects
Cancer Research ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Time Factors ,Population ,Urine ,Biology ,3 methyl 4 dimethylaminoazobenzene ,Excretion ,p-Dimethylaminoazobenzene ,Internal medicine ,medicine ,Animals ,education ,Methyldimethylaminoazobenzene ,education.field_of_study ,Incidence (epidemiology) ,Liver Neoplasms ,Neoplasms, Experimental ,digestive system diseases ,Rats ,Immunodiffusion ,Regimen ,Endocrinology ,Oncology ,Female ,alpha-Fetoproteins ,Alpha Foetoprotein ,Research Article - Abstract
Female rats were maintained on standard laboratory diet, Miller's diet or Miller's diet containing 3'MeDAB. Animals fed standard or Miller's diet did not excrete alpha-foetoprotein (AFP) in their urine. Early appearance of AFP was demonstrated by examining the urine of rats on the 3'MeDAB regimen. The incidence of positive urine samples was high between the 5th and 7th week of the experiment. It thereafter declined, but from the 3rd month it steadily rose and reached a maximum of 80% at about 10 months. Though urinary excretion of AFP was irregular in individual animals, several positive urine samples were obtained from all rats followed for more than a few months. The urine of 90% of hepatoma-bearing rats contained AFP at the time of killing. The incidence of elevated serum AFP levels as determined by immunodiffusion, increased with the duration of the experiment, but was still only 70 percent in rats fed 3'MeDAB for over 34 weeks. The severity of the hepatic alterations, as well as hepatocytic uptake of [3H]thymidine, increased with time. The serum of animals fed the standard diet was negative, whereas AFP was very infrequently detected in the serum of rats given Miller's hypoprotein diet. The results demonstrate that, in a population exposed to hepatocarcinogenic agent, the recurring detection of urinary excretion of AFP is a useful indicator of the high risk of developing hepatomas. Images Fig. 2 Fig. 3 Fig. 5
- Published
- 1977
38. Antigen-Antibody Precipitates and Immunoadsorbents. Application to Purification of Alpha-Foetoprotein
- Author
-
Erkki Ruoslahti
- Subjects
0303 health sciences ,Pediatrics ,medicine.medical_specialty ,biology ,Chemistry ,Immunology ,General Medicine ,Molecular biology ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,030220 oncology & carcinogenesis ,biology.protein ,medicine ,Antibody ,Alpha Foetoprotein ,030304 developmental biology - Published
- 1976
39. Purification of rabbit alpha-foetoprotein (RAFP) and the identification of molecular variants
- Author
-
Brian S. Slade and Lorraine E. Clarke
- Subjects
Amniotic fluid ,Crossed immunoelectrophoresis ,Immunology ,Size-exclusion chromatography ,Obstetrics and Gynecology ,Biology ,Reproductive Medicine ,Affinity chromatography ,Biochemistry ,Concanavalin A ,biology.protein ,Immunology and Allergy ,Polyacrylamide gel electrophoresis ,Alpha Foetoprotein - Abstract
A method of isolating rabbit alpha-foetoprotein (RAFP) from amniotic fluid, liver extract and foetal and neonatal serum is described. RAFP was purified by a stepwise procedure involving gel filtration, preparative polyacrylamide gel electrophoresis and concanavalin A affinity chromatography. Monomeric and dimeric forms of RAFP were present in purified extracts. Four molecular variants of RAFP have been identified by concanavalin A chromatography and crossed immunoelectrophoresis.
- Published
- 1980
40. STUDIES ON MATURITY IN NEWBORN INFANTS
- Author
-
ORVAR FINNSTRÖM, BÖRJE KARLSSON, and BO ZETTERLUND
- Subjects
Fetal Proteins ,medicine.medical_specialty ,Pediatrics ,Birth weight ,media_common.quotation_subject ,Gestational Age ,Growth ,Birth Weight ,Humans ,Medicine ,Serum Albumin ,media_common ,business.industry ,Obstetrics ,Infant, Newborn ,Gestational age ,General Medicine ,Fetal Blood ,University hospital ,Maturity (psychological) ,% total haemoglobin ,Cord blood ,embryonic structures ,Pediatrics, Perinatology and Child Health ,Apgar Score ,Gestation ,alpha-Fetoproteins ,business ,Alpha Foetoprotein - Abstract
Finnstrom, O., Gothefors, L. and Zetterlund, B. (Departments of Paediatrics, University Hospitals, Linkoping and Umea, Sweden). Studies on maturity in newborn infants. VII. Foetal haemoglobin. Acta Paediatr Scand, 64:404, 1975.–Cord blood from 125 newborns of various gestational ages has been analysed for the ratio foetal haemoglobin to total haemoglobin, using an alkali denaturation method. The quotient, percentage of foetal haemoglobin divided by birth weight correlates well with gestational age. Thus the percentage of foetal haemoglobin in cord blood can be used as a method for estimating maturity in newborn infants. Foetal haemoglobin has been compared with other methods for maturity assessments and seems to give the same precision in estimating gestational age as the best of these, which is the scoring of external characteristics. However, the latter method is considerably less time-consuming and more suitable for routine use.
- Published
- 1975
41. Increased reactivity of rat alpha-foetoprotein with corresponding antiserum after 125I labelling
- Author
-
Ph. Sizaret and C. Dambuyant
- Subjects
Fetal Proteins ,Antiserum ,Dose-Response Relationship, Drug ,Chemistry ,Immune Sera ,Immunology ,Temperature ,Radioimmunoassay ,digestive system diseases ,Rats ,Iodine Radioisotopes ,Biochemistry ,Labelling ,Animals ,Immunology and Allergy ,Electrophoresis, Polyacrylamide Gel ,Reactivity (chemistry) ,Rabbits ,alpha-Fetoproteins ,Alpha Foetoprotein - Abstract
Two rat alpha-foetoproteins (AFP) of different origin and purified according to two different techniques were labelled with 125I using an identical procedure. After labelling the reactivity of one of these AFPs was not modified whereas that of the other was markedly increased; this in spite of a greater purity made the latter unsuitable for the radioimmunoassay of rat AFP. The observed difference may be due to the technique of purification and brings additional evidence for the necessity of checking the reactivity of tracers.
- Published
- 1975
42. The ontogeny of alpha-foetoprotein in the foetal and neonatal rabbit, and its experimental induction in adult rabbits
- Author
-
W. R. Branch
- Subjects
Fetal Proteins ,Immunodiffusion ,Cancer Research ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Nitrosamines ,Diethylamines ,Ontogeny ,Gestational Age ,Andrology ,Necrosis ,Fetus ,Pregnancy ,Alpha-Globulins ,medicine ,Animals ,Immunoelectrophoresis ,Carbon Tetrachloride Poisoning ,business.industry ,Liver Neoplasms ,digestive, oral, and skin physiology ,Age Factors ,Neoplasms, Experimental ,digestive system diseases ,Liver Regeneration ,Surgery ,Animals, Newborn ,Oncology ,Neonatal rabbit ,embryonic structures ,Gestation ,Electrophoresis, Polyacrylamide Gel ,Female ,Rabbits ,business ,Alpha Foetoprotein - Abstract
The relative concentration of AFP in the foetal and neonatal rabbit was studied by immunological methods. A peak foetal concentration of AFP was found between the 24th and 26th days of gestation. AFP could not be detected in newborn serum after the 28th day post-partum. The concentration of AFP between the 20th and 25th days of gestation was found to rise from 327 mg/100 ml to 525 mg/100 ml. The synthesis of AFP in young and adult rabbits was successfully induced (a) during liver regeneration following carbon tetrachloride intoxication in rabbits less than 14 weeks of age, and (b) following the induction of hepatomas by oral administration of N.nitrosodiethylamine. L'ONTOGENIE DE L'ALPHA-FœTOPROTeINE CHEZ LE FETUS DE LAPIN OU LE LAPIN NOUVEAU-NE ET SON INDUCTION EXPERIMENTALE CHEZ LES LAPINS ADULTES La concentration relative de l'AFP chez le fœtus de lapin ou le lapin nouveau-ne a ete etudiee par des methodes immunologiques. On observe une concentration maximale d'AFP chez le fœtus entre le vingt-quatrieme et le vingt-sixieme jour de gestation. On ne decele plus d'AFP dans le serum de lapin nouveau-ne apres le vingt-huitieme jour post-partum. La concentration de l'AFP entre le vingtieme et le vingt-cinquieme jour de gestation est passee de 327 mg/100 ml a 525 mg/100 ml. La synthese de l'AFP chez les lapereaux et les lapins adultes a pu ětre induite a) pendant la regeneration du foie apres intoxication des lapins de moins de 14 semaines par le tetrachlorure de carbone et b) apres l'induction d'hepatomes par administration orale de N. nitrosodiethylamine.
- Published
- 1972
43. Immunofluorescent study of alpha-foetoprotein (αfp) in liver and liver tumours. I. Technique of αfp localization in tissue sections
- Author
-
L. Ja. Shipova, N. V. Engelhardt, A. I. Goussev, and G. I. Abelev
- Subjects
Cancer Research ,Pathology ,medicine.medical_specialty ,Immunosorbent technique ,medicine.diagnostic_test ,business.industry ,Liver tumours ,Immunofluorescence ,Molecular biology ,Tissue sections ,Primary Liver Carcinoma ,Oncology ,medicine ,business ,Alpha Foetoprotein ,Liver parenchyma ,Histological examination - Abstract
Sections of paraffin-embedded tissue blocks fixed by ethanol/acetic acid were found to be very suitable for immunofluorescent (IF) study of αfp. In paraffin blocks the antigen was preserved for at least 1 year. It was possible to prepare serial sections for routine histological examination and simultaneous IF localization of several antigens practically in the same cells. Antibodies to αfp were obtained by glutaraldehyde immunosorbent technique. Their monospecificity was controlled by IF reaction on the αfp-negative sections and by neutralization with pure αfp. To differentiate αfp localization due to passive serum uptake from specific sites of αfp production or storage, a simultaneous study of αfp and γ-globulin γG distribution was performed. Only the structures containing αfp without γG were regarded as specifically connected with αfp metabolism. These were liver parenchyma cells in foetal and newborn liver and tumour cells in human primary liver carcinoma. Etude par Immunofluorescence de L'a-fcetoproteine (ufp) Dans le Foie et les Tumeurs Hepatiques. I. Technique de Localisation de L'afp Dans les Coupes Tissulaires Nous avons observe que des coupes tissulaires enrobees de paraffine et fixees a l'acide ethanol-acetique conviennent parfaitement a l'etude par immunofluorescence (IF) de l'afp. L'antigene s'est conserve au moins un an dans les blocs de paraffine. Nous avons pu preparer des coupes en serie pour l'examen histologique systematique et pour la localisation simultanee par IF de divers antigenes pratiquement dans les měmes cellules. Nous avons obtenu des anticorps a l'αfp par la methode d'immuno-absorption au glutaraldehyde. Leur monospecificie a ete contrǒlee par reaction d'IF sur les coupes αfp-negatives et par neutralisation au moyen d'αfp pure. Afin de differencier la localisation de l'αfp due a l'incorporation passive de serum des sites specifiques de production ou de stockage de l'αfp, nous avons effectue une etude simultanee de la distribution de l'αfp et de la γ-globuline (γg). Seules les structures contenant de l'αfp mais pas de γg ont ete considerees comme secifiquement liees au metabolisme de l'αfp. II sagissait des cellules parenchymateuses du foie de fαtus et de nouveau-ne et des cellules tumorales de carcinomes primitifs du foie humain.
- Published
- 1971
44. Carbohydrate antigen 19-9 as a serum marker of hepatocellular carcinoma: Comparison with alpha-foetoprotein
- Author
-
M. C. Kew, E. L. Berger, and H. Koprowski
- Subjects
Adult ,Male ,Cancer Research ,Pathology ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Adolescent ,Biology ,Antigens, Neoplasm ,Neoplasms ,medicine ,Humans ,Antigens, Tumor-Associated, Carbohydrate ,Aged ,Aged, 80 and over ,Liver Diseases ,Liver Neoplasms ,Middle Aged ,medicine.disease ,digestive system diseases ,Oncology ,Hepatocellular carcinoma ,Female ,alpha-Fetoproteins ,Antigens neoplasm ,Alpha Foetoprotein ,Carbohydrate antigen ,Research Article ,Serum markers - Abstract
Carbohydrate antigen 19-9 as a serum marker of hepatocellular carcinoma: Comparison with alpha-foetoprotein
- Published
- 1987
45. Paraneoplastic syndromes
- Abstract
There are two types of clinical and biochemical syndromes not directly associated with the invasiveness and metastatic ability of the tumour; the first type is represented by the hormonal paraneoplastic syndromes. The second type consists of certain neurological diseases or abnormalities observed in patients with malignant tumours not directly affecting the nervous system. While the hormonal type is well established and rests on solid ground, the neurological type is less well defined and more controversial. © 1981 Pergamon Press Ltd., SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 1981
46. Results of the second international study on the W.H.O. alpha-foetoprotein standard
- Author
-
A.H. Orr, T. Waldmann, L.R. Muenz, N. Martel, B.P. Krebs, S. Nishi, C. Bernard, K. Kithier, J. Kohn, R. McIntire, R. Masseyeff, F.G. Lehmann, G.L. Princier, P. Sizaret, J.A. Chayvialle, and S. Reynaud
- Subjects
medicine.medical_specialty ,Amniotic fluid ,business.industry ,Normal serum ,World Health Organization ,Gastroenterology ,Radioimmunoassay technique ,General Biochemistry, Genetics and Molecular Biology ,Titer ,Internal medicine ,Immunology ,medicine ,Methods ,Humans ,alpha-Fetoproteins ,Primary liver cancer ,business ,Alpha Foetoprotein - Abstract
Ten preparations containing various levels of alpha-foetoprotein have been assayed by eight different laboratories in an international collaborative study of the W.H.O. alpha-foetoprotein standard. Included among the preparations, all of which were analyzed by the radioimmunoassay technique, were normal serum, sera from women before and after delivery, sera from teratoblastoma, alcoholic cirrhosis, and primary liver cancer patients, and amniotic fluid. The study establishes the validity of the W.H.O. standard for specimens with a wide range of AFP titer. Results have lower variability when expressed in comparison with the W.H.O. standard than when compared with the local standard used in each laboratory. Within-laboratory variability was some 2·5 times as great using the local standard but both standards show important differences between laboratories; the worst laboratory had more than 10 times greater within-laboratory variance (of the log concentration) than the best after all assays failing a rigorous test of technical validity had already been removed. Agreement between laboratories was better for preparations with more than 45 international units of alpha-foetoprotein/ml such as sera from women in the second half of gestation. For preparations with very low AFP content, such as normal human sera, only one laboratory was capable of providing dose-response curves parallel to that of the standard. A statistical technique (cubic splines) is discussed which allows useful information to be extracted from poor or oddly shaped assay curves. It is also noted, however, that an experienced laboratory worker is often even more effective in recovering results from bad assays.
- Published
- 1978
47. Antibodies to alpha-foetoprotein cause foetal mortality in rabbits
- Author
-
Slade B
- Subjects
Fetal Proteins ,Multidisciplinary ,Sheep ,biology ,Ontogeny ,Antibodies ,Peak concentration ,Andrology ,Specific antibody ,In vivo ,Pregnancy ,Immunology ,Total serum protein ,Alpha-Globulins ,biology.protein ,Gestation ,Animals ,Female ,Rabbits ,Antibody ,Alpha Foetoprotein ,Fetal Death ,Maternal-Fetal Exchange - Abstract
α-FOETOPROTEiNS (AFP) have been observed in the serum of all mammalian species so far studied1,2. In the rabbit AFP constitutes about 33% of the total serum protein on day 20 of gestation and reaches a peak concentration around days 24 to 26 (ref. 3). This ontogenic pattern is similar to that of the rat where maximum concentration is also reached late in gestation, but differs from the human where a steady decline occurs after the first trimester4,5. Although considerable interest has attached to the reappearance of AFP in the serum of adult animals and human patients with hepatocellular cancer6–9, little attention has been given to the possible role of this protein in normal development. The preliminary experiments reported here were designed to investigate this aspect by selectively neutralising AFP in vivo with specific antibodies.
- Published
- 1973
48. Maturation of the inhibitory feedback action of oestrogen on follicle-stimulating hormone secretion in the immature female rat: a role for alpha-foetoprotein
- Author
-
P. Kramer and H. M. A. Meijs-Roelofs
- Subjects
endocrine system ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,media_common.quotation_subject ,Microgram ,Inhibitory postsynaptic potential ,Ethinyl Estradiol ,Feedback ,Endocrinology ,Internal medicine ,medicine ,Animals ,Castration ,Sexual Maturation ,Ovulation ,media_common ,Estradiol ,Chemistry ,Uterus ,Follicle-stimulating hormone secretion ,Organ Size ,Rats ,FSH secretion ,Hormone receptor ,Ovariectomized rat ,Female ,alpha-Fetoproteins ,Follicle Stimulating Hormone ,Alpha Foetoprotein ,hormones, hormone substitutes, and hormone antagonists - Abstract
The maturation of the inhibitory feedback action of oestrogen on FSH secretion in the immature female rat was studied from 5 days of age until after the first ovulation. To study the role of the oestrogen binding alpha-foetoprotein (AFP) which is present in the blood of young animals, the effects of various doses of oestradiol and of the synthetic oestrogen R2858 (11β-methoxy-17-ethynyl-oestradiol), which is not bound by AFP, were compared in ovariectomized rats. A rise in the serum concentration of FSH within 2 days of ovariectomy was first observed in rats ovariectomized at 8 days of age. Between 8 and 28 days of age the rise in FSH after ovariectomy could be prevented by oestrogen injections in such a way that the resulting FSH concentration amounted to 50% of that in ovariectomized control rats. This was achieved with a constant dose of 0·00015 μg R2858/100 g body weight, whereas the dose of oestradiol needed decreased from 0·05 to 0·01 μg/100 g body weight indicating an increased sensitivity to the feedback action of oestradiol. After day 28, sensitivity to the feedback action of both R2858 and oestradiol decreased progressively up to the time of the first ovulation. In contrast to results at earlier ages, none of the doses of either oestrogen was capable of maintaining near-physiological concentrations of FSH after 20 days of age. It is concluded that the apparent increase in sensitivity to the feedback action of oestradiol occurring before 28 days of age reflects the disappearance of AFP from the blood, whereas the subsequent decrease in sensitivity is independent of AFP. Moreover, it is concluded that up to about 20 days of age oestradiol could be, though not necessarily is, the sole ovarian factor involved in regulating FSH secretion, whereas at later ages additional steroids and/or factors must be involved.
- Published
- 1979
49. Lack of suppressive effect of alpha-foetoprotein on development of experimental allergic encephalomyelitis in rats
- Author
-
Michael J. Parmely, Nancy E. Goeken, Philip Y. Paterson, John S. Thompson, and Robert S. Fujinami
- Subjects
Multidisciplinary ,Carcinoma, Hepatocellular ,Encephalomyelitis, Autoimmune, Experimental ,Experimental allergic ,business.industry ,Encephalomyelitis ,Liver Neoplasms ,Neoplasms, Experimental ,medicine.disease ,Rats ,Immunology ,medicine ,Animals ,alpha-Fetoproteins ,business ,Alpha Foetoprotein - Abstract
Lack of suppressive effect of α-foetoprotein on development of experimental allergic encephalomyelitis in rats
- Published
- 1976
50. Oestrone binding properties of nine molecular variants of rat alpha-foetoprotein
- Author
-
Claude Aussel, Jean-Pierre Kerckaert, and Bernard Bayard
- Subjects
Chemistry ,Estrone ,Binding properties ,Amniotic Fluid ,Biochemistry, Genetics and Molecular Biology (miscellaneous) ,Molecular biology ,Chromatography, Affinity ,Sialic acid ,Rats ,Molecular Weight ,Electrophoresis ,chemistry.chemical_compound ,Kinetics ,Affinity chromatography ,Biochemistry ,Pregnancy ,Lectins ,Ricinus communis agglutinin ,Animals ,Female ,alpha-Fetoproteins ,Binding site ,Alpha Foetoprotein - Abstract
Rat alpha-foetoprotein was separated into nine molecular variants by electrophoresis and affinity chromatography on Ricinus communis agglutinin and concanavalin-A. The nine variants are able to bind oestrone with the same capacity of one binding site per alpha-foetoprotein molecule. The association constants seem to vary with the sialic acid composition of the iso-alpha-foetoprotein.
- Published
- 1978
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.